Carlson Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-400
Closed -$205K 165
2022
Q4
$205K Buy
+400
New +$203K 0.01% 158

Other funds holding ELV

Carlson Capital Management's ELV Position: Q1 2023 in Review

Carlson Capital Management sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 400 shares — an estimated $205K sold.

Carlson Capital Management first reported a position in ELV in Q4 2022 and held it in 1 quarter. The position peaked at $205K in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Carlson Capital Management reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Carlson Capital Management sold 400 Elevance Health shares in Q1 2023, an estimated $205K.
  • Carlson Capital Management first reported a position in Elevance Health in Q4 2022 and held it in 1 quarter.
  • Carlson Capital Management's Elevance Health position peaked at $205K in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Carlson Capital Management's 13F filing for Q1 2023, filed 17 Apr 2023.